Promoting â€˜Make In Indiaâ€™ Initiative in Pharmaceutical Sector
The Government has taken various measures to promote the â€˜Make in Indiaâ€™ initiative in pharmaceutical sector. In this direction, the Government had constituted a Committee under the chairmanship of Secretary, Department of Health Research. The mandate of this Committee was to carefully study the whole issue of APIs of critical importance by identifying important APIs and then working out a package of interventions/concessions required to build domestic production capabilities and examine the cost implications. The committee which has since submitted its recommendation has, inter-alia, recommended establishment of Mega Parks for APIs with common facilities such as common Effluent Treatments Plants (ETPs), Testing facilities, Captive Power Plants/assured power supply by state systems, Common Utilities/Services such as storage, testing laboratories, IPR management, designing etc., maintained by a separate Special Purpose Vehicles (SPV).
These recommendations are being examined for formulation of a Policy for Promotion of Manufacturing of Bulk Drugs.
This information was given by the Union Minister of Chemicals and Fertilizers Shri Ananth Kumar in the Lok Sabha today.